...
search icon
fenc-img

Fennec Pharmaceuticals Inc Share Price

FENC
NAQ
$8.71
-$0.07
(-0.8%)
1D
Industry: Biotechnology Sector: Health Care

Fennec Pharmaceuticals Inc Analyst Forecast

Fennec Pharmaceuticals Inc Share Price Chart

Fennec Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$299.87M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
7.24K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.77
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.68 L
$9.92 H
$8.71

About Fennec Pharmaceuticals Inc, Common Stock

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina. more

Industry: BiotechnologySector: Health Care

Fennec Pharmaceuticals Inc Stock Returns

Time FrameFENCSectorS&P500
1-Week Return7.07%0.81%0.49%
1-Month Return18.81%1.2%1.02%
3-Month Return7.33%3.24%3.34%
6-Month Return11%14.99%7.04%
1-Year Return32.23%7.42%11.68%
3-Year Return-2.66%20.71%71.63%
5-Year Return8.66%37.45%75.56%
10-Year Return407.51%138.53%257.55%

Fennec Pharmaceuticals Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue170.00K170.00K1.47M21.25M47.54M[{"date":"2020-12-31","value":0.36,"profit":true},{"date":"2021-12-31","value":0.36,"profit":true},{"date":"2022-12-31","value":3.1,"profit":true},{"date":"2023-12-31","value":44.71,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue--82.59K1.26M3.18M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":2.59,"profit":true},{"date":"2023-12-31","value":39.54,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit170.00K-1.39M19.99M44.35M[{"date":"2020-12-31","value":0.38,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":3.14,"profit":true},{"date":"2023-12-31","value":45.08,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin100.00%-94.40%94.08%93.30%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":94.4,"profit":true},{"date":"2023-12-31","value":94.08,"profit":true},{"date":"2024-12-31","value":93.3,"profit":true}]
Operating Expenses18.05M17.07M23.09M32.76M41.79M[{"date":"2020-12-31","value":43.21,"profit":true},{"date":"2021-12-31","value":40.85,"profit":true},{"date":"2022-12-31","value":55.25,"profit":true},{"date":"2023-12-31","value":78.41,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(17.89M)(17.07M)(21.69M)(12.77M)2.57M[{"date":"2020-12-31","value":-696.46,"profit":false},{"date":"2021-12-31","value":-664.78,"profit":false},{"date":"2022-12-31","value":-844.78,"profit":false},{"date":"2023-12-31","value":-497.31,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(539.00K)(193.92K)(2.01M)(6.17M)(5.12M)[{"date":"2020-12-31","value":-53900000,"profit":false},{"date":"2021-12-31","value":-19391700,"profit":false},{"date":"2022-12-31","value":-201242400,"profit":false},{"date":"2023-12-31","value":-616700000,"profit":false},{"date":"2024-12-31","value":-511500000,"profit":false}]
Pre-Tax Income(18.11M)(17.19M)(22.77M)(16.05M)(71.00K)[{"date":"2020-12-31","value":-1810900000,"profit":false},{"date":"2021-12-31","value":-1719337200,"profit":false},{"date":"2022-12-31","value":-2277438700,"profit":false},{"date":"2023-12-31","value":-1604500000,"profit":false},{"date":"2024-12-31","value":-7100000,"profit":false}]
Income Taxes(187.00K)110.00K1.13M1.00365.00K[{"date":"2020-12-31","value":-16.62,"profit":false},{"date":"2021-12-31","value":9.78,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":32.44,"profit":true}]
Income After Taxes(17.92M)(17.30M)(23.90M)(16.05M)(436.00K)[{"date":"2020-12-31","value":-1792200000,"profit":false},{"date":"2021-12-31","value":-1730337200,"profit":false},{"date":"2022-12-31","value":-2389938700,"profit":false},{"date":"2023-12-31","value":-1604500100,"profit":false},{"date":"2024-12-31","value":-43600000,"profit":false}]
Income From Continuous Operations(18.11M)(17.35M)(23.71M)(20.22M)(436.00K)[{"date":"2020-12-31","value":-1810900000,"profit":false},{"date":"2021-12-31","value":-1734600000,"profit":false},{"date":"2022-12-31","value":-2371400000,"profit":false},{"date":"2023-12-31","value":-2022000000,"profit":false},{"date":"2024-12-31","value":-43600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(18.11M)(17.19M)(22.77M)(16.05M)(436.00K)[{"date":"2020-12-31","value":-1810900000,"profit":false},{"date":"2021-12-31","value":-1719337200,"profit":false},{"date":"2022-12-31","value":-2277438700,"profit":false},{"date":"2023-12-31","value":-1604500000,"profit":false},{"date":"2024-12-31","value":-43600000,"profit":false}]
EPS (Diluted)(0.77)(0.67)(0.90)(0.61)-[{"date":"2020-12-31","value":-77,"profit":false},{"date":"2021-12-31","value":-67,"profit":false},{"date":"2022-12-31","value":-90,"profit":false},{"date":"2023-12-31","value":-61,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]

Fennec Pharmaceuticals Inc Ratios

Fennec Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

FENC
Cash Ratio 2.24
Current Ratio 4.69
Quick Ratio 4.44

Fennec Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

FENC
ROA (LTM) -5.39%
ROE (LTM) -1005.59%

Fennec Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

FENC
Debt Ratio Lower is generally better. Negative is bad. 1.09
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.09

Fennec Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

FENC
Trailing PE NM
Forward PE 13.07
P/S (TTM) 7.90
P/B 57.93
Price/FCF 205
EV/R 6.72
EV/Ebitda 20.27

FAQs

What is Fennec Pharmaceuticals Inc share price today?

Fennec Pharmaceuticals Inc (FENC) share price today is $8.71

Can Indians buy Fennec Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Fennec Pharmaceuticals Inc (FENC) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in FENC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Fennec Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Fennec Pharmaceuticals Inc (FENC) via the Vested app. You can start investing in Fennec Pharmaceuticals Inc (FENC) with a minimum investment of $1.

How to invest in Fennec Pharmaceuticals Inc shares from India?

You can invest in shares of Fennec Pharmaceuticals Inc (FENC) via Vested in three simple steps:

  • Click on Sign Up or Invest in FENC stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Fennec Pharmaceuticals Inc shares
What is Fennec Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Fennec Pharmaceuticals Inc (FENC) is $9.92. The 52-week low price of Fennec Pharmaceuticals Inc (FENC) is $4.68.

What is Fennec Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Fennec Pharmaceuticals Inc (FENC) is

What is Fennec Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Fennec Pharmaceuticals Inc (FENC) is 57.93

What is Fennec Pharmaceuticals Inc dividend yield?

The dividend yield of Fennec Pharmaceuticals Inc (FENC) is 0.00%

What is the Market Cap of Fennec Pharmaceuticals Inc?

The market capitalization of Fennec Pharmaceuticals Inc (FENC) is $299.87M

What is Fennec Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of Fennec Pharmaceuticals Inc is FENC

How Can Investors Use Fennec Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Fennec Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Fennec Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Fennec Pharmaceuticals Inc shares for Indian investors?

When investing in Fennec Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Fennec Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Fennec Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Fennec Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Fennec Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top